CIK: 0001542339
Total reported value
$250.5M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | MDXG | Mimedx Group INC | Stock-Other | 46.09% | -15.52% | — | |
| 2 | RVNCEUR | Revance Therapeutics INC | Stock-Other | 24.58% | — | — | |
| 3 | AXGN | Axogen INC | Stock-Other | 9.21% | — | — | |
| 4 | EYPT | Eyepoint INC | Stock-Other | 7.16% | -0.65% | — | |
| 5 | TELA | Tela Bio INC | Stock-Other | 5.76% | -0.95% | — | |
| 6 | ✓ | Stock-Other | 5.57% | — | — | ||
| 7 | MNOV | Medicinova INC | Stock-Other | 1.51% | +0.14% | — | |
| 8 | ✓ | Gyre Therapeutics INC Com | Stock-Other | 0.13% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Gyre Therapeutics INC Com | -0.1% | — | Unchanged |
| 2 | MNOV | Medicinova INC | -1.6% | — | Unchanged |
| 3 | AXGN | Axogen INC | -3% | — | Unchanged |
| 4 | TELA | Tela Bio INC | -7.2% | — | Unchanged |
| 5 | ✓ | -9.7% | — | Unchanged | |
| 6 | RVNCEUR | Revance Therapeutics INC | -20.1% | — | Unchanged |
| 7 | MDXG | Mimedx Group INC | — | NEW | New buy |
| 8 | EYPT | Eyepoint INC | — | NEW | New buy |
| 9 | PSDVUSD | Eyepoint Pharmaceuticals INC | — | EXIT | Sold out |
| 10 | ELGXEUR | Endologix INC | — | EXIT | Sold out |